You can buy or sell SpringWorks and other stocks, options, and ETFs commission-free!
SpringWorks Therapeutics, Inc. Common Stock, also called SpringWorks, is a clinical-stage biopharmaceutical company, which engages in applying a precision medicine approach to acquiring, developing and commercializing medicines. It focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer. Its pipeline include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT. The listed name for SWTX is SpringWorks Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, Pre-Market